Zimmer Stock Today

ZBH -  USA Stock  

USD 128.43  2.94  2.34%

Market Performance
0 of 100
Odds Of Distress
Less than 37
Zimmer Biomet is trading at 128.43 as of the 7th of December 2021. This is a 2.34 percent increase since the beginning of the trading day. The stock's open price was 125.49. Zimmer Biomet has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Zimmer Biomet Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of October 2021 and ending today, the 7th of December 2021. Click here to learn more.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. The company has 208.48 M outstanding shares of which 3.31 M shares are at this time shorted by investors with about 2.1 days to cover. More on Zimmer Biomet Holdings

Zimmer Biomet Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Zimmer Biomet's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Zimmer Biomet or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Over 92.0% of the company outstanding shares are owned by institutional investors
Latest headline from www.marketwatch.com: Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Legal NameZimmer Biomet Holdings
CEO and President and DirectorDavid Dvorak  (View All)
Thematic Classification
Currently Active Investing Idea (view all)
  Obamacare Repeal
Average Analyst Recommendation
Analysts covering Zimmer Biomet report their recommendations after researching Zimmer Biomet's financial statements, talking to executives and customers, or listening in on Zimmer Biomet's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Zimmer Biomet Holdings. The Zimmer consensus assessment is calculated by taking the average forecast from all of the analysts covering Zimmer Biomet.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Zimmer Biomet Holdings based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Zimmer Biomet Holdings financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 6 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares189.6 M207 M
Significantly Down
Increasing
Slightly volatile
Weighted Average Shares Diluted190.2 M207 M
Significantly Down
Increasing
Slightly volatile
Net Cash Flow from Operations1.2 B1.2 B
Fairly Down
Increasing
Slightly volatile
Total Assets20.4 B24.4 B
Fairly Down
Increasing
Slightly volatile
Total Liabilities10.3 B12.2 B
Fairly Down
Increasing
Slightly volatile
Current Assets4.5 B5.1 B
Fairly Down
Increasing
Slightly volatile
Current Liabilities2.1 B2.6 B
Significantly Down
Increasing
Slightly volatile
Total Debt11.2 B10.3 B
Significantly Up
Increasing
Slightly volatile
Return on Average Assets(0.58)(0.5663)
Fairly Down
Decreasing
Slightly volatile
Gross Margin78.5669.7018
Moderately Up
Decreasing
Stable
Asset Turnover0.380.2856
Significantly Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Zimmer Biomet's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Zimmer Biomet's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Zimmer Biomet's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zimmer Biomet's financial leverage. It provides some insight into what part of Zimmer Biomet's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Zimmer Biomet's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Zimmer Biomet deploys its capital and how much of that capital is borrowed.
Liquidity
Zimmer Biomet cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 7.87 B in debt with debt to equity (D/E) ratio of 0.63, which is OK given its current industry classification. Zimmer Biomet Holdings has a current ratio of 1.79, which is typical for the industry and considered as normal.

Operating Cash Flow

1.17 BillionShare
Zimmer Biomet Holdings (ZBH) is traded on New York Stock Exchange in USA and employs 20,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 25.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zimmer Biomet's market, we take the total number of its shares issued and multiply it by Zimmer Biomet's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Zimmer Biomet Holdings runs under Healthcare sector within Medical Devices industry. The entity has 208.48 M outstanding shares of which 3.31 M shares are at this time shorted by investors with about 2.1 days to cover. Zimmer Biomet Holdings has about 1.04 B in cash with 1.51 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.99.
Check Zimmer Biomet Probability Of Bankruptcy
Ownership
Zimmer Biomet Holdings owns a total of 208.48 Million outstanding shares. The majority of Zimmer Biomet outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zimmer Biomet Holdings to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zimmer Biomet Holdings. Please pay attention to any change in the institutional holdings of Zimmer Biomet Holdings as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Zimmer Ownership Details

Zimmer Stock Price Odds Analysis

What are Zimmer Biomet's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Zimmer Biomet jumping above the current price in 90 days from now is about 79.37%. The Zimmer Biomet Holdings probability density function shows the probability of Zimmer Biomet stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Zimmer Biomet has a beta of 0.9361. This usually means Zimmer Biomet Holdings market returns are reactive to returns on the market. As the market goes up or down, Zimmer Biomet is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Zimmer Biomet Holdings is significantly underperforming DOW.
 Odds Down 128.43HorizonTargetOdds Up 128.43 
20.55%90 days
 128.43 
79.37%
Based on a normal probability distribution, the odds of Zimmer Biomet to move above the current price in 90 days from now is about 79.37 (This Zimmer Biomet Holdings probability density function shows the probability of Zimmer Stock to fall within a particular range of prices over 90 days) .

Zimmer Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Zimmer Biomet that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zimmer Biomet's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zimmer Biomet's value.
InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares21.6 M3.2 B
Vanguard Group IncCommon Shares16.2 M2.4 B
View Zimmer Biomet Diagnostics

Zimmer Biomet Historical Income Statement

Zimmer Biomet Holdings Income Statement is one of the three primary financial statements used for reporting Zimmer's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Zimmer Biomet Holdings revenue and expense. Zimmer Biomet Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Zimmer Biomet Earning Before Interest and Taxes EBIT is most likely to decrease significantly in the upcoming years. The last year's value of Earning Before Interest and Taxes EBIT was reported at 396.54 Million. The current Interest Expense is estimated to increase to about 278.3 M, while Direct Expenses is projected to decrease to roughly 1.8 B. View More Fundamentals

Zimmer Stock Against Markets

Picking the right benchmark for Zimmer Biomet stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Zimmer Biomet stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Zimmer Biomet is critical whether you are bullish or bearish towards Zimmer Biomet Holdings at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Zimmer Biomet without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Zimmer Biomet Corporate Directors

Zimmer Biomet corporate directors refer to members of a Zimmer Biomet board of directors. The board of directors generally takes responsibility for the Zimmer Biomet's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Zimmer Biomet's board members must vote for the resolution. The Zimmer Biomet board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Arthur Higgins - Independent DirectorProfile
Michael Michelson - Independent DirectorProfile
Cecil Pickett - Independent DirectorProfile
Jeffrey Rhodes - DirectorProfile
Check out Your Current Watchlist. Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet Holdings price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine Zimmer Biomet value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.